We have been asked to evaluate the possibility of preparing autologous serum eyedrops (SED). There are numerous issues ranging from regulatory (in NY SED use is considered a blood derivative "re-infusion"), preparation standards - eg USP <797>, to infection control considerations.
If you do prepare SED in your pharmacy would you be willing to share your procedures?

If you allow use of SED in inpatients (either patient "own" or institutionally prepared), how do you handle specifics of dispensing, storage and infectious disease exposure risk to staff and environment?

Any assistance is greatly appreciated!

Tim Lesar
Albany Medical Center